MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.37% | 66.53% | 220.78% | -196.86% | -37.31% |
| Total Depreciation and Amortization | -3.80% | 8.05% | -5.90% | -35.60% | -38.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.19% | -909.72% | 113.32% | 106.64% | -18.65% |
| Change in Net Operating Assets | -8,106.71% | -79.33% | 52.91% | -90.87% | -100.92% |
| Cash from Operations | -2.73% | -36.99% | 270.69% | -2,029.49% | -255.67% |
| Capital Expenditure | 63.74% | 0.00% | -18.64% | -261.89% | -306.41% |
| Sale of Property, Plant, and Equipment | -- | -- | 700.00% | 48.15% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.27% | 6.71% | 209.31% | 142.73% | -7.74% |
| Cash from Investing | -60.06% | 6.81% | 206.19% | 141.80% | -11.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -41.97% | -88.46% | 184.23% | 324.96% |
| Repurchase of Common Stock | 88.21% | -- | 47.52% | 14.29% | -1,413.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -213.71% | -43.22% | -100.14% | 959.32% | -99.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.91% | -70.93% | 607.39% | 103.10% | -117.85% |